Canada's DRI Healthcare annual income hits record, raises distribution

DRI Healthcare Trust

04/03/2026 24:22

Overview

Canada's pharma royalty firm reported a total income of $61.7 mln in Q4 and a record of $198.6 mln for the year

Adjusted EBITDA margin for Q4 was 91%

Subsequent to quarter-end, the company announced a quarterly distribution increase to $0.11 per unit for 2026

Outlook

DRI Healthcare expects 2026 adjusted EBITDA between $157 mln and $162 mln

Company aims for $800 mln to $1 bln capital deployment from 2026 to 2030

DRI Healthcare plans low teens CAGR for adjusted EBITDA from 2026 to 2030

Result Drivers

INTERNALIZATION BENEFITS - DRI Healthcare completed the internalization of its investment management function, with benefits pacing ahead of schedule, contributing to a 91% adjusted EBITDA margin

CAPITAL DEPLOYMENT - Achieved five-year deployment target of $1.25 bln, including potential near-term milestone payments

Company press release: ID:nCNWB4vHya

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Total Income
$61.69 mln
Q4 Adjusted Cash Earnings per Unit
$0.77
Q4 Net Income
$8.77 mln
Q4 Adjusted EBITDA
$46.24 mln
Q4 Adjusted EBITDA Margin
91.00%


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the pharmaceuticals peer group is "buy"

Wall Street's median 12-month price target for Dri Healthcare Trust is C$20.72, about 26.7% above its March 3 closing price of C$16.35

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)